Company Information & Drug Savings for Iovance Biotherapeutics, Inc. Medications

Iovance Biotherapeutics is a biotechnology company developing tumor-infiltrating lymphocyte (TIL) cell therapies for cancer. Based in San Carlos, California, Iovance created Amtagvi (lifileucel), a personalized T-cell therapy for advanced melanoma. The company’s adoptive cell therapy platform harnesses patients’ own immune cells to fight solid tumor cancers.